Evidence map›Paper›PMID 37376604›Full record

ArticleViruses2023

High Incidence of Respiratory Syncytial Virus in Children with Community-Acquired Pneumonia from a City in the Brazilian Pre-Amazon Region.

Valéria Fontes, Hivylla Ferreira, Marilene Ribeiro, Aruanã Pinheiro, Carlos Maramaldo, Eduardo Pereira, Luís Batista, Antonio Júnior, Luis Lobato, Fabiano Silva and 9 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Valéria FontesLaboratory of Virology, Post-Graduate Programme in Microbial Biology, CEUMA University, São Luís, MA 65075-120, Brazil.
Hivylla FerreiraCentral Public Health Laboratory of Maranhão-LACEN-MA, Osvaldo Cruz Institute, São Luís, MA 65020-904, Brazil.ORCID 0000-0002-7822-3410
Marilene RibeiroHospital of Federal University of Maranhão, HU-UFMA, São Luís, MA 65020-070, Brazil.
Aruanã PinheiroPostdoctoral Program in Microbial Biology, CEUMA University, São Luís, MA 65075-120, Brazil.ORCID 0000-0002-1201-2311
Carlos MaramaldoCentral Public Health Laboratory of Maranhão-LACEN-MA, Osvaldo Cruz Institute, São Luís, MA 65020-904, Brazil.
Eduardo PereiraLaboratory of Virology, Post-Graduate Programme in Microbial Biology, CEUMA University, São Luís, MA 65075-120, Brazil.ORCID 0000-0002-2266-9771
Luís BatistaPostgraduate Program in Adult Health (PPGSAD), Federal University of Maranhão, UFMA, São Luís, MA 65080-805, Brazil.
Antonio JúniorPostgraduate Program in Adult Health (PPGSAD), Federal University of Maranhão, UFMA, São Luís, MA 65080-805, Brazil.
Luis LobatoCentral Public Health Laboratory of Maranhão-LACEN-MA, Osvaldo Cruz Institute, São Luís, MA 65020-904, Brazil.ORCID 0000-0003-1401-0245
Fabiano SilvaCentral Public Health Laboratory of Maranhão-LACEN-MA, Osvaldo Cruz Institute, São Luís, MA 65020-904, Brazil.
Luis SousaLaboratory of Virology, Post-Graduate Programme in Microbial Biology, CEUMA University, São Luís, MA 65075-120, Brazil.ORCID 0000-0002-7121-1417
Washington LimaPost-Graduate Programme in Biodiversity and Biotechnology (BIONORTE), CEUMA University, São Luís, MA 65075-120, Brazil.
Claudia LimaLaboratory of Virology, Post-Graduate Programme in Microbial Biology, CEUMA University, São Luís, MA 65075-120, Brazil.
Suzany SoczekPost-Graduate Programme in Biotechnology Applied to Child and Adolescent Health, Pelé Pequeno Príncipe Research Institute, Curitiba, PR 80250-060, Brazil.
Rafael CarvalhoPostgraduate Program in Adult Health (PPGSAD), Federal University of Maranhão, UFMA, São Luís, MA 65080-805, Brazil.ORCID 0000-0001-7073-8308
Mirleide SantosEvandro Chagas Institute, Ananindeua, PA 67030-000, Brazil.
Elizabeth FernandesPost-Graduate Programme in Biotechnology Applied to Child and Adolescent Health, Pelé Pequeno Príncipe Research Institute, Curitiba, PR 80250-060, Brazil.
Eduardo SousaLaboratory of Virology, Post-Graduate Programme in Microbial Biology, CEUMA University, São Luís, MA 65075-120, Brazil.ORCID 0000-0002-2506-169X
Lidio NetoLaboratory of Virology, Post-Graduate Programme in Microbial Biology, CEUMA University, São Luís, MA 65075-120, Brazil.
Universidade Ceuma · BRUniversidade Federal do Maranhão · BRFundação Oswaldo Cruz · BRHospital Universitário da Universidade Federal do Maranhão · BRInstituto Evandro Chagas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlthough fewer children have been affected by the severe form of the coronavirus disease 2019 (COVID-19), community-acquired pneumonia (CAP) continues to be the leading global cause of child hospitalizations and deaths.

aimThis study investigated the incidence of respiratory syncytial virus (RSV) as well its subtypes (RSV A and B), adenovirus (ADV), rhinovirus (HRV), metapneumovirus (HMPV), coronavirus (NL63, OC43, 229E and HKU1), parainfluenza virus subtypes (PI1, PI2 and PI3), bocavirus and influenza A and B viruses (FluA and FluB) in children diagnosed with CAP during the COVID-19 pandemic.

methodsA total of 200 children with clinically confirmed CAP were initially recruited, of whom 107 had negative qPCR results for SARS-CoV-2 and were included in this study. Viral subtypes were identified using a real-time polymerase chain reaction in the nasopharyngeal swab samples.

resultsViruses were identified in 69.2% of the patients. RSV infections were the most frequently identified (65.4%), with type RSV B being the most prevalent (63.5%). In addition, HCoV 229E and HRV were detected in 6.5% and 3.7% of the patients, respectively. RSV type B was associated with severe acute respiratory infection (ARI) and a younger age (less than 24 months).

conclusionsNew strategies for preventing and treating viral respiratory infections, particularly RSV infections, are necessary.

Indexed as

Community-Acquired InfectionsCOVID-19PneumoniaRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsBrazilChildChild, PreschoolHumansIncidenceInfantPandemicsSARS-CoV-2childclinical epidemiologyrespiratory tract infections

Identifiers

PMID37376604
PMCPMC10305439
OpenAlexW4379054757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.